View Older Stories View More Recent Stories
-
LeddarTech Announces Participation in Upcoming Fourth Quarter 2023 Investor Conferences
-
Biofrontera (BFRI) Announces $4.5 Million Registered Direct Offering of Common Stock, Warrants
-
Biofrontera Inc. Announces $4.5 Million Registered Direct Offering Priced At-the-market Under NASDAQ Rules
-
Cohen & Company Capital Markets Continues Strong Momentum, Appoints Gary Quin Senior Advisor, EMEA Investment Banking to Expand Global Reach
-
Tesla CEO Musk's demand warning sparks selloff in EV stocks
-
ROTH MKM Announces the Addition of Jason Wittes to its Healthcare Research Team
-
New Era Helium and Accretion Acquisition Corp. Announce Letter of Intent for Proposed Business Combination
-
New Era Helium to Go Public via Merger with Accretion Acquisition Corp (ENER)
-
New Era Helium and Accretion Acquisition Corp. Announce Letter of Intent for Proposed Business Combination
-
Shimmick Corporation (SHIM) Announces Proposed IPO
-
Genasys Announces Closing of $10 Million Public Offering of Common Stock
-
ProSomnus Announces Participation in the 2023 Roth Capital Healthcare Opportunities Conference
-
RenovoRx to Present at the ROTH MKM Healthcare Opportunities Conference on October 12, 2023
-
ORYZON to Provide Corporate Progress Updates at Several Events in October
-
Helius Medical Technologies to Participate at Two Upcoming Healthcare Conferences
-
Genasys (GNSS) Prices 5M Share Offering at $2/sh
-
Genasys Announces Pricing of $10 Million Public Offering of Common Stock
-
Genasys (GNSS) Announces Proposed Public Offering of Common Stock
-
Genasys Announces Proposed Public Offering of Common Stock
-
Snow Lake Announces Closing of Premium Priced Flow-Through Offering of CDN$7.7 Million
-
Transcat (TRNS) Prices 737K Share Offering at $95/sh
-
Transcat, Inc. Prices $70 Million Public Offering of Common Stock
-
Histogen Inc. (HSTO) Announces Board Approval of Complete Liquidation and Dissolution
-
Histogen Announces Board Approval of Complete Liquidation and Dissolution
-
SLR Welcomes Chris York as a Partner
-
First Wave BioPharma (FWBI) Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.0 Million Gross Proceeds Priced At-the-Market
-
First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.0 Million Gross Proceeds Priced At-the-Market
-
Evolution Petroleum and PEDEVCO Enter into Strategic Partnership to Jointly Develop PEDEVCO’s Chaveroo Field in the Permian Basin
-
Evolution Petroleum and PEDEVCO Enter into Strategic Partnership to Jointly Develop PEDEVCO’s Chaveroo Field in the Permian Basin
-
ROTH MKM Announces the Addition of Sustainability Analyst Chip Moore, CFA - Managing Director and Senior Research Analyst
-
MiningNewsBreaks – Riley Exploration Permian Inc. (NASDAQ: REPX) Enters into ATM Agreement
-
ROTH MKM to Host 10th Annual Solar & Storage Symposium at Solar Power International & RE+ 2023
-
ROTH MKM to Host 10th Annual Solar & Storage Symposium at Solar Power International & RE+ 2023
-
Asure Software, Inc. Announces Closing of Public Offering of Common Stock
-
Nuvo Group to Become Public Company Via Business Combination with LAMF Global Ventures Corp. I (LGVC)
-
Nuvo Group Ltd., an FDA-Cleared Leading Innovator in Pregnancy Care, to Become a Public Company Via Business Combination with LAMF Global Ventures Corp. I
-
Asure Software (ASUR) Prices 3.33M Share Offering at $12/sh
-
Asure Software, Inc. Announces Pricing of Public Offering of Common Stock
-
Flotek Announces Entry into Asset Based Loan Agreement
-
CEA Industries Inc. Reports Second Quarter 2023 Results and Initiates Review of Strategic Alternatives
-
Addimmune to Go Public via Merger with 10X Capital Venture Acquisition Corp. III (VCXB)
-
Correction: Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to go Public Through Business Combination With 10X Capital Venture Acquisition Corp. III
-
Correction: Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to go Public Through Business Combination With 10X Capital Venture Acquisition Corp. III
-
Addimmune, a Clinical Stage Hiv-Focused Gene Therapy Company, to go Public Through Business Combination With 10x Capital Venture Acquisition Corp. III
-
Addimmune, a Clinical Stage Hiv-Focused Gene Therapy Company, to go Public Through Business Combination With 10x Capital Venture Acquisition Corp. III
-
Sunworks (SUNW) Announces 3.3M Share Offering at $1/sh
-
Sunworks Announces $3.3 Million Registered Direct Offering of Common Stock
-
Bio-Path Holdings (BPTH) Prices 3.5M Share Offering at $0.60/sh
-
Bio-Path Holdings, Inc. Announces Pricing of $2.1 Million Public Offering
-
Global Crossing Airlines Announces Closing of US$35 Million Financing with Axar Capital Management LLC
